Global Pharmaceutical Excipients Market - Strategic Insights and Forecasts (2026-2031)

The global pharmaceutical excipients market is forecast to grow at a CAGR of 9.2%, reaching USD 15.28 billion in 2031 from USD 9.84 billion in 2026.

Excipients are pharmacologically dormant substances included in conjunction with the dynamic medicate substance to streamline the production of the drug item and help in lubricity, flowability, dissolution, and taste. They may bestow a few forms of antimicrobial work and additionally encourage the physiological absorption of the drug. A few of the excipients utilized in pharmaceutical industries include fillers, binders, oils, flavouring agents, sweeteners, chelating agents, solvents, co-solvents, etc. To supply the bulk dose formulations steady in physical and chemical properties, the formulator is profoundly subordinate to the pharmaceutical excipients.

A few pharmaceutical dosage forms that are easily and widely available and utilized globally are tablets, capsules, topical creams and gels, implants, oral dosage, eye drops, injectable products, inhalers, transdermal patches, lozenges, and suppositories. Pharmaceutical excipients are utilized in these pharmaceutical medication formulations to help the processing, providing bulk or volume to the API, and securing, supporting, or incrementing the stability of the dosage forms in the final product.

Cancer, acute respiratory disease, heart stroke, diabetes, and other chronic diseases are the major driving factors of rising mortality in the world. Inside the United States alone, six out of ten individuals endure chronic illness regularly and require a persistent and regular pharmaceutical regimen. As per the International Diabetes Federation (IDF), around 463 million people (20-79 years adults) were living with diabetes in 2019, and by 2045, the number is expected to increase to 700 million, showing a rise in demand for medicines, in turn boosting the Pharmaceutical Excipients market growth. 

Pharmaceutical Excipients Market Drivers:

•  Increasing research and development (R&D) is expected to boost the pharmaceutical excipients market.

Expanded investigations and advancements in pharmaceutical formulations utilize multi-functional excipients to progress the process of production and medication quality. Excipients play a significant part in helping pharmaceutical manufacturers give progressive support by improving compliance and treatment viability.

The pharmaceutical industry's rising attention on R&D is anticipated to emphatically affect the industry for pharmaceutical excipients. These inert substances improve medication stability and solubility and help in medication delivery forms. They play a vital part in medication advancement, influencing the bioavailability, discharge profile, and stability of dynamic drugs. R&D endeavours drive advancement in pharmaceutical medication details, with progressed delivery systems such as nanoparticles and liposomes frequently requiring specialized excipients.

Administrative bodies, just like the FDA and EMA, continuously upgrade regulations, standard guidelines and benchmarks for pharmaceutical items, driving the requirement for excipients that meet the most recent measures. Customization of medication formulations on the basis of particular patient needs and restorative zones is significant. As pharmaceutical companies contribute to R&D all-inclusive, the request for pharmaceutical excipients is likely to extend around the world, with producers seeing expanded opportunities to supply to broader regions in the years ahead.

• A rise in chronic diseases is expected to surge the pharmaceutical excipients market growth.

The rising generics medicine industry is driven by the rise in chronic illnesses and the improvement of excipients, which are a key factor in the growth of the pharmaceutical market. The rise in major chronic disorders, like cardiovascular disease, diabetes, cancer, and chronic respiratory conditions, is fueling the demand for different treatment alternatives.

Pharmaceutical companies are creating innovative medication formulations to fulfill the requirement, as well as emerging delivery frameworks to progress adequacy and effectiveness while ensuring patient comfort and compliance. These medicines frequently include complex regimens, requiring pharmaceutical excipients to improve the stability of the medicine, control release rates of the drug, and enhance its bioavailability. Specialized drug delivery systems are necessary for sustained release, targeted delivery to specific tissues, and overcoming solubility and absorption issues. 

Pharmaceutical excipients can also be used to create patient-friendly dosage forms, such as extended-release tablets or convenient oral formulations. Innovations in therapeutic approaches, such as personalized medicine and biologics, often require specialized excipients for stability and effectiveness. Government initiatives and healthcare policies aimed at improving access to effective treatments for chronic diseases may contribute to the pharmaceutical excipient market growth.

Pharmaceutical Excipients Market Restraints:

• Cost and time consumed in creating new excipients could hinder the market growth.

Pharmaceutical Excipients require mandatory inspections by the regulatory authorities of the manufacturing site. The industry lacks separate guidelines for approval, and the manufacturing of excipients is impeding R&D initiatives related to excipients. If a new drug approval fails, the excipient also fails, even if it is not related to the excipient. Moreover, a considerable amount of time and cost goes into creating an excipient.

Pharmaceutical Excipients Market Developments:

• February 2026: Lubrizol Life Science Health launched next-generation pharmaceutical excipient polymers for poorly soluble drugs, supporting enhanced bioavailability, formulation stability, and advanced drug delivery applications across pharmaceutical development programs.

• October 2025: Evonik Industries received the CPHI Pharma Award for EUDRACAP® colon, recognizing its innovative pharmaceutical excipient technology enabling targeted oral delivery of sensitive active pharmaceutical ingredients.

• October 2025: Roquette Health & Pharma Solutions showcased its expanded pharmaceutical excipients and drug delivery portfolio following the integration of Qualicaps and IFF Pharma Solutions at CPHI Frankfurt 2025.

• September 2025: Evonik Industries launched MaxiPure® Polysorbate 80, an ultra-high-purity pharmaceutical excipient designed for injectable biologics, improving protein stability, solubilization, and viral inactivation in parenteral drug formulations.

• June 2025: Ashland Global Holdings Inc. introduced advanced pharmaceutical excipient solutions for biologics and injectable drug formulations, expanding functional excipient offerings focused on stability, solubility enhancement, and formulation performance optimization.

• March 2025: Colorcon launched enhanced film-coating excipient systems supporting modified-release pharmaceutical formulations, improving tablet stability, manufacturing efficiency, and formulation flexibility for pharmaceutical manufacturers worldwide.

Pharmaceutical Excipients Market Scope: 

Pharmaceutical Excipients Market Segmentation:

• By Excipient Type

  • Polymers

  • Alcohols

  • Sugars

  • Minerals

  • Others

• By Formulation Type

  • Oral

  • Topical

  • Parenteral

  • Others

• By Functionality

  • Coating Agents

  • Flavoring Agents & Sweeteners

  • Lubricants & Glidants

  • Colorants

  • Emulsifying Agents

  • Buffering Agents

  • Others

• By Distribution Channel

  • Online

  • Offline

• By Geography

  • North America

    • USA

    • Canada

    • Mexico

  • South America

    • Brazil

    • Argentina

    • Others

  • Europe

    • Germany

    • France

    • United Kingdom

    • Italy 

    • Spain

    • Others

  • Middle East and Africa

    • Saudi Arabia

    • UAE

    • Israel

    • Others

  • Asia Pacific

    • China

    • Australia

    • Japan

    • South Korea

    • India

    • Thailand

    • Taiwan

    • Indonesia

    • Others